REQUEST A DEMO
Total
USD $0.00
Search more companies

Benedek-Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Benedek-Pharma Gyogyszertar Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Benedek-Pharma Bt. is a company based in Hungary, with its head office in Salgotarjan. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on November 26, 2004. There are currently 7 (2024) people employed by Benedek-Pharma Bt.. In 2023, the company reported a net sales revenue drop of 3.87%. Its’ total assets recorded a negative growth of 10.44%. Benedek-Pharma Bt.’s net profit margin decreased by 0.78% in 2023.

Headquarters
Bem Jozsef u. 14-16 SPAR Aruhaz
Salgotarjan; Nograd; Postal Code: 3100

Contact Details: Purchase the Benedek-Pharma Bt. report to view the information.

Website: http://www.szbenedek.hu

Basic Information
Total Employees:
Purchase the Benedek-Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Benedek-Pharma Bt. report to view the information.
Registered Capital:
Purchase the Benedek-Pharma Bt. report to view the information.
Financial Auditors:
Purchase the Benedek-Pharma Bt. report to view the information.
Incorporation Date:
November 26, 2004
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Benedek-Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-3.87%
Total operating revenue
-3.36%
Operating profit (EBIT)
-14.19%
EBITDA
-12.4%
Net Profit (Loss) for the Period
-14.88%
Total assets
-10.44%
Total equity
-14.9%
Operating Profit Margin (ROS)
-0.84%
Net Profit Margin
-0.78%
Return on Equity (ROE)
0.03%
Quick Ratio
-0.33%
Cash Ratio
-0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?